Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes.

Genetics in Medicine : Official Journal of the American College of Medical Genetics
Brian H ShirtsBrian L Browning

Abstract

Up to half of unique genetic variants in genomic evaluations of familial cancer risk will be rare variants of uncertain significance. Classification of rare variants will be an ongoing issue as genomic testing becomes more common. We modified standard power calculations to explore sample sizes necessary to classify and estimate relative disease risk for rare variant frequencies (0.001-0.00001) and varying relative risk (20-1.5), using population-based and family-based designs focusing on breast and colon cancer. We required 80% power and tolerated a 10% false-positive rate because variants tested will be in known genes with high pretest probability. Using population-based strategies, hundreds to millions of cases are necessary to classify rare cancer variants. Larger samples are necessary for less frequent and less penetrant variants. Family-based strategies are robust to changes in variant frequency and require between 8 and 1,175 individuals, depending on risk. It is unlikely that most rare missense variants will be classifiable in the near future, and accurate relative risk estimates may never be available for very rare variants. This knowledge may alter strategies for communicating information about variants of uncertain si...Continue Reading

References

Jun 19, 1998·American Journal of Human Genetics·G M PetersenD Thomas
Jun 16, 2000·Journal of the National Cancer Institute. Monographs·L P ZhaoR Prentice
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas S FrankGregory C Critchfield
Aug 6, 2003·American Journal of Human Genetics·Deborah ThompsonDavid E Goldgar
Mar 3, 2005·European Journal of Human Genetics : EJHG·Geraldine R VinkEgbert Bakker
Feb 24, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mark A JenkinsSteven Gallinger
Apr 18, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Mark A JenkinsMelissa C Southey
Oct 27, 2006·Critical Reviews in Oncology/hematology·M H Nieuwenhuis, H F A Vasen
Feb 22, 2007·Annals of the New York Academy of Sciences·Alan S Ziegler
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sining Chen, Giovanni Parmigiani
Oct 28, 2008·Human Mutation·David E GoldgarUNKNOWN IARC Unclassified Genetic Variants Working Group
Oct 28, 2008·Human Mutation·Sharon E PlonUNKNOWN IARC Unclassified Genetic Variants Working Group
Feb 14, 2009·Psycho-oncology·Suzanne C O'NeillMarc D Schwartz
Jul 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kishore GudaSanford D Markowitz
Mar 9, 2010·Nature Genetics·Zhiwu ZhangEdward S Buckler
May 27, 2010·Nature Genetics
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Tom WalshMary-Claire King
Oct 29, 2010·Nature·Gonçalo R AbecasisGil A McVean
Mar 31, 2012·Human Mutation·Erica ClarkeMichael O Woods
May 19, 2012·Science·Jacob A TennessenUNKNOWN NHLBI Exome Sequencing Project
Sep 24, 2013·American Journal of Human Genetics·Michael O DorschnerGail P Jarvik

❮ Previous
Next ❯

Citations

Jul 7, 2015·Current Genetic Medicine Reports·Adam A NishimuraBrian H Shirts
Apr 4, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Melanie G PepinPeter H Byers
May 28, 2015·The New England Journal of Medicine·Barbara J EvansGail P Jarvik
Oct 10, 2014·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Barbara J Evans
Oct 27, 2017·International Journal of Technology Assessment in Health Care·James D ChambersKathryn A Phillips
Jun 5, 2019·Journal of Genetic Counseling·Ginger J TsaiBrian H Shirts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Genetics in Medicine : Official Journal of the American College of Medical Genetics
Val V ZvereffKenneth J Friedman
Genetics in Medicine : Official Journal of the American College of Medical Genetics
Jipin Das KChristopher Semsarian
Genetics in Medicine : Official Journal of the American College of Medical Genetics
Caitlin B MauerDavid M Euhus
© 2021 Meta ULC. All rights reserved